Advice
Following an abbreviated submission
Levetiracetam 750 mg film coated tablets are accepted for restricted use in NHS Scotland as an additional dosage form for adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in patients for whom therapy is appropriate. Its use should be initiated by physicians who have appropriate experience in the treatment of epilepsy. The budget impact for NHS Scotland is likely to be small.
Download detailed advice23KB (PDF)
Medicine details
- Medicine name:
- levetiracetam (Keppra®) 750 mg tablets
- SMC ID:
- 150/04
- Indication:
- Epilepsy
- Pharmaceutical company
- UCB Pharma Ltd
- BNF chapter
- Central nervous system
- Submission type
- Abbreviated
- Status
- Restricted
- Date advice published
- 10 January 2005